The Conversation (0)
NanoSphere Health Sciences (CSE:NSHS) got featured in CFN Media for their recently developed innovative delivery technology that solves important issues around cannabinoid bioavailability. “With an existing licensing agreement, the company is also well on its way to commercialization after spending more than a decade fine-tuning its technology–and developing products that have applications across an array …
NanoSphere Health Sciences (CSE:NSHS) got featured in CFN Media for their recently developed innovative delivery technology that solves important issues around cannabinoid bioavailability.
“With an existing licensing agreement, the company is also well on its way to commercialization after spending more than a decade fine-tuning its technology–and developing products that have applications across an array of industries.” The article states.
The article describes the issue of bioavailability a major problem facing the medical cannabis industry.
It further talks about the company’s patent-pending delivery system which he absorption issues associated with a wide variety of products.
“NanoSphere Health Sciences Inc. (CSE: NSHS) (OTC: NSHSF) represents a compelling investment opportunity in the legal cannabis industry.”, concludes the article.
To read the full article click here
Click here to connect with NanoSphere Health Sciences (CSE:NSHS) for an investor presentation
